Search results (15)
« Back to PublicationsNeurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation.
Journal article
Wong MMK. et al, (2018), Acta Neuropathol Commun, 6
A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells.
Journal article
Watson LM. et al, (2018), Cerebellum, 17, 419 - 427
Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Journal article
Watson LM. et al, (2017), Am J Hum Genet, 101
Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Journal article
Watson LM. et al, (2017), Am J Hum Genet, 101
Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.
Journal article
Watson LM. et al, (2017), Am J Hum Genet, 101, 451 - 458
Recent advances in modelling of cerebellar ataxia using induced pluripotent stem cells.
Journal article
Wong MMK. et al, (2017), J Neurol Neuromedicine, 2, 11 - 15
Spinocerebellar ataxia type 7 in South Africa: Epidemiology, pathogenesis and therapy.
Journal article
Watson L. et al, (2016), S Afr Med J, 106, S107 - S109
Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.
Journal article
Watson LM. et al, (2015), Open Biol, 5
Corrigendum: Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7.
Journal article
Tan JY. et al, (2015), Nat Struct Mol Biol, 22
Allele-specific silencing of mutant Ataxin-7 in SCA7 patient-derived fibroblasts.
Journal article
Scholefield J. et al, (2014), Eur J Hum Genet, 22, 1369 - 1375
Allele-specific silencing of mutant Ataxin-7 in SCA7 patient-derived fibroblasts
Journal article
Scholefield J. et al, (2014), European journal of human genetics : EJHG, 22, 1369 - 1375
Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7.
Journal article
Tan JY. et al, (2014), Nat Struct Mol Biol, 21, 955 - 961
Inherited polyglutamine spinocerebellar ataxias in South Africa.
Journal article
Smith DC. et al, (2012), S Afr Med J, 102, 683 - 686
RNA therapy for polyglutamine neurodegenerative diseases.
Journal article
Watson LM. and Wood MJA., (2012), Expert reviews in molecular medicine, 14
Polyglutamine disease: from pathogenesis to therapy.
Journal article
Watson LM. et al, (2012), S Afr Med J, 102, 481 - 484